Hypertension and heart failure: A dysfunction of systole, diastole or both?

Journal of Human Hypertension

Volumn 23, Issue 5, 2009, Pages 295-306

  Yip, G W ^a   Fung, J W H ^a   Tan, Y T ^b   Sanderson, J E ^b  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHRONOTROPISM; DIASTOLIC DYSFUNCTION; DIASTOLIC HYPERTENSION; ECHOCARDIOGRAPHY; EXERCISE TEST; HEART DILATATION; HEART EJECTION FRACTION; HEART FAILURE; HEART LEFT VENTRICLE DILATATION; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE FIBROSIS; HEART MUSCLE OXYGEN CONSUMPTION; HEART OUTPUT; HEART VENTRICLE FIBROSIS; HEART VENTRICLE REMODELING; HUMAN; HYPERTENSION; HYPERTENSIVE HEART FAILURE; REVIEW; SYSTOLIC DYSFUNCTION; SYSTOLIC HEART FAILURE; SYSTOLIC HYPERTENSION;

ADAPTATION, PHYSIOLOGICAL; CARDIOMYOPATHY, HYPERTROPHIC; COMORBIDITY; DIASTOLE; DISEASE PROGRESSION; ECHOCARDIOGRAPHY; FIBROSIS; HEART FAILURE; HUMANS; HYPERTENSION; HYPERTROPHY; HYPERTROPHY, LEFT VENTRICULAR; STROKE VOLUME; SYSTOLE; VENTRICULAR DYSFUNCTION; VENTRICULAR REMODELING;

EID: 67349287063     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/jhh.2008.141     Document Type: Review

References (125)

1. Lawes CMM, Vander Hoorn S, Rodgers A, for the International Society of Hypertension. Global burden of blood-pressure-related disease, 2001. Lancet 2008; 371: 1513-1518.
2. Dzau VJ, Antman EM, Black HR, Hayes DL, Manson JE, Plutzky J et al The cardiovascular disease continuum validated: Clinical evidence of imProved patient outcomes: Part I: pathophysiology and clinical trial evidence (risk factors through stable coronary artery disease). Circulation 2006; 114: 2850-2870.
3. Dzau VJ, Antman EM, Black HR, Hayes DL, Manson JE, Plutzky J et al The cardiovascular disease continuum validated: Clinical evidence of improved patient outcomes: Part II: Clinical trial evidence (acute coronary syndromes through renal disease) and future directions. Circulation 2006; 114: 2871-2891.
4. Dzau V. The cardiovascular continuum and renin-angiotensin-aldosterone system blockade. J Hypertens 2005; 23(Suppl 1): S9-S17.
5. Opie LH, Commerford PJ, Gersh BJ, Pfeffer MA. Controversies in ventricular remodelling. Lancet 2006; 367: 356-367.
6. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991; 325: 293-302.
7. Mathew J, Sleight P, Lonn E, Johnstone D, Pogue J, Yi Q et al. Heart Outcomes Prevention Evaluation (HOPE) Investigators. Reduction of cardiovascular risk by regression of electrocardiographic markers of left ventricular hypertrophy by the angiotensin-converting enzyme inhibitor ramipril. Circulation 2001; 104: 1615-1621.
8. Packer M, Coats AJ, Fowler MB, Katus HA, Krum H, Mohacsi P et al. Carvedilol Prospective Randomized Cumulative Survival Study Group. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 2001; 344: 1651-1658.
9. Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 2006; 355: 251-259.
10. Bhatia RS, Tu JV, Lee DS, Austin PC, Fang J, Haouzi A et al. Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med 2006; 355: 260-269.
11. Tribouilloy C, Rusinaru D, Mahjoub H, Souliere V, Levy F, Peltier M et al. Prognosis of heart failure with preserved ejection fraction: A 5 year prospective population-based study. Eur Heart J 2008; 29 339-347.
12. Fung JW, Sanderson JE, Yip GW, Zhang Q, Yu CM. Impact of Atrial Fibrillation in Heart Failure with Normal Ejection Fraction: A Clinical and Echocardiographic Study. J Card Fail 2007; 13: 649-655.
13. Yusuf S, Pfeffer MA, Swedberg K, Granger CB, Held P, McMurray JJ et al. CHARM Investigators and Committees. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: The CHARM-Preserved Trial. Lancet 2003; 362 777-781.
14. Cleland JG, Tendera. M, Adamus J, Freemantle N, Polonski L, Taylor J. The perindopril in elderly people with chronic heart failure (PEP-CHF) study. Eur Heart J 2006; 27: 2338-2345.
15. Yip GW, Wang M, Wang T, Chan S, Fung JW, Yeung L et al. The Hong Kong diastolic heart failure study: A randomised controlled trial of diuretics, irbesartan and ramipril on quality of life, exercise capacity, left ventricular global and regional function in heart failure with a normal ejection fraction. Heart 2008; 94:573-580.
16. Carson P, Massie BM, McKelvie R, McMurray J, Komajda M, Zile M et al The irbesartan in heart failure with preserved systolic function (I-PRESERVE) trial: Rationale and design, J Card Fail 2005; 11 576-585.
17. Baicu CF, Zile MR, Aurigemma GP, Gaasch WH. Left ventricular systolic performance, function, and contractility in patients with diastolic heart failure. Circulation 2005; 111: 2306-2312.
18. Brutsaert DL. Cardiac dysfunction in heart failure: The cardiologist's love affair with time. Prog Cardiovasc Dis 2006; 49: 157-181.
19. Sanderson JE. Heart failure with a normal ejection Fraction. Heart 2007; 93: 155-158.
20. Ouzounian M, Lee DS, Liu PP. Diastolic heart failure: Mechanisms and controversies. Nat Clin Pract Cardiovasc Med 2008; 5(7): 375-386.
21. Yip G, Wang M, Zhang Y, Fung JW, Ho PY, Sanderson JE. Left ventricular long axis function in diastolic heart failure is reduced in both diastole and systole: Time for a redefinition? Heart 2002; 87 121-125.
22. Yu CM, Lin H, Yang H, Kong SL, Zhang Q, Lee SW. Progression of systolic abnormalities in patients with 'isolated' diastolic heart failure and diastolic dysfunction. Circulation 2002; 105: 1195-1201.
23. Petrie MC, Caruana L, Berry C, McMurray JJV. 'Diastolic heart failure' or heart failure caused by subtle left ventricular systolic dysfunction? Heart 2002; 87: 29-31.
24. Nikitin NP, Witte KK, Clark AL, Cleland JGF. Color tissue Doppler-derived long-axis left ventricular function in heart failure with preserved global systolic function. Am J Cardiol 2002; 90 1174-1177.
25. Bruch C, Gradaus R, Gunia S, Breithardt G, Wichter T. Doppler tissue analysis of mitral annular velocities: Evidence for systolic abnormalities in patients with diastolic heart failure. J Am Soc Echocardiogr 2003; 16: 1031-1036.
26. Vinereanu D, Nicolaides E, Tweddel AC, Fraser AG. 'Pure' diastolic dysfunction is associated with long-axis systolic dysfunction. Implications for the diagnosis and classification of heart failure. Eur J Heart Fail 2005; 7: 820-828.
27. Levy D, Larson MG, Vasan RS, Kannel WB, Ho KK. The progression from hypertension to congestive heart failure. JAMA 1996; 275: 1557-1562.
28. Lakatta EG, Levy D. Arterial and cardiac aging: Major shareholders in caAdiovascAlar disease enterprises: Part 1: aging arteries: a 'set up' for vascular disease. Circulation 2003; 107: 139-146.
29. O'Rourke MF, Hashimoto J. Mechanical factors in arterial aging. J Am Coll Cardiol 2007; 50: 1-13.
30. Devereux RB, Roman MJ. Left ventricular hypertrophy in hypertension: stimuli, patterns, and consequences. Hypertens Res 1999; 22: 1-9.
31. Hoffman J, Buckberg G. The myocardial supply:dEmand ratio - a critical review. Am J Cardiol 1978; 41: 327-332.
32. Hoffman JI. A critical review of coronary reserve. Circulation 1987; 75: I6-I11.
33. Ferro G, Duilio C, Spinelli L, Liucci GA, Mazza F, Indolfi C. Relationship between diastolic perfusion pressure time and coronary artery stenosis during stress-induced myocardial ischemia. Circulation 1995; 92: 342-347.
34. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990; 322: 1561-1566.
35. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 1991; 114 345-352.
36. Vasan RS, Larson MG, Benjamin EJ, Evans JC, Levy D. Left ventricular dilatation and the risk of congestive heart failure in people without myocardial infarction. N Engl J Med 1997; 336: 1350-1355.
37. Haider AW, Larson MG, Benjamin EJ, Levy D. Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death. J Am Coll Cardiol 1998; 32: 1454-1459.
38. Susic D, Frohlich ED. The aging hypertensive heart: A brief update. Nat Clin Pract Cardiovasc Med 2008; 5: 104-110.
39. Mudd JO, Kass DA. Tackling heart failure in the twenty-first century. Nature 2008; 45: 919-928.
40. Hill JA, Olson EN. Cardiac plasticity. N Engl J Med 2008; 358 1370-1380.
41. Weber KT. Fibrosis and hypertensive heart disease. Curr Opin Cardiol 2000; 15: 264-272.
42. Lopez B, Gonzalez A, Varo N, Laviades C, Querejeta R, Diez J. Biochemical assessment of myocardial fibrosis in hypertensive heart disease. Hypertension 2001; 38: 1222-1226.
43. Spinale FG. Myocardial matrix remodeling and the matrix metalloproteinases: Influence on cardiac form and function. Physiol Rev 2007; 87: 1285-1342.
44. Querejeta R, Lopez B, Gonzalez A, Sanchez E, Larman M, Martinez Ubago JL et al. Increased collagen type I sythesis in patients with heart failure of hypertensive origin: Relation to myocardial fibrosis. Circulation 2004; 110: 1263-1268.
45. Martos R, Baugh J, Ledwidge M, O'Loughlin C, Conlon C, Patle A et al Diastolic heart failure: Evidence of increased myocardial collagen turnover linked to diastolic dysfunction. Circulation 2007;115 888-895.
46. Ahmed SH, Clark LL, Pennington WR, Webb CS, Bonnema DD, Leonardi AH et al. Matrix metalloproteinases/tissue inhibitors of metalloproteinases: Relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease. Circulation 2006; 113: 2089-2096.
47. Lopez B, Gonzalez A, Querejeta R, Larman M, Diez J. Alterations in the pattern of collagen deposition may contribute to the deterioration of systolic function in hypertensive patients with heart failure. J Am Coll Cardiol 2006; 48: 89-96.
48. Shirwany A, Weber KT. Extracellular matrix remodeling in hypertensive heart disease. J Am Coll Cardiol 2006; 48: 97-98.
49. Lorell BH, Carabello BA. Left ventricular hypertrophy: Pathogenesis, detection, and prognosis. Circulation 2000; 102: 470-479.
50. Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Battistelli M, Bartoccini C et al. Adverse prognostic significance of concentric remodeling of the left ventricle in hypertensive patients with normal left ventricular mass. J Am Coll Cardiol 1995; 25: 871-878.
51. Sadler DB, Aurigemma GP, Williams DW, Reda DJ, Materson BJ, Gottdiener JS. Systolic function in hypertensive men with concentric remodeling. Hypertension 1997; 30: 777-781.
52. de Simone G, Devereux RB, Koren MJ, Mensah GA, Casale PN, Laragh JH. Midwall left ventricular mechanics: An independent predictor of cardiovascular risk in arterial hypertension. Circulation 1996; 93: 259-265.
53. Aurigemma GP, Gottdiener JS, Shemanski L, Gardin J, Kitzman D. Predictive value of systolic and diastolic function for incident congestive eart failure in the elderly: The Cardiovascular Health Study. J Am Coll Cardiol 2001; 37: 1042-1048.
54. Aurigemma GP, Silver KH, Priest MA, Gaasch WH. Geometric changes allow normal ejection fraction despite depressed myocardial shortening in hypertensive left ventricular hypertrophy. J Am Coll Cardiol 1995; 26: 195-202.
55. Palmon LC, Reichek N, Yeon SB, Clark NR, Brownson D, Hoffman E et al Intramural myocardial shortening in hypertensive left ventricular hypertrophy with normal pump function. Circulation 1994; 89: 122-131.
56. Palka P, Lange A, Fleming AD, Donnelly JE, Dutka DP, Starkey IR et al Differences in myocardial velocity gradient measured throughout the cardiac cycle in patients with hypertrophic cardiomyopathy, athletes and patients with left ventricular hypertrophy due to hypertension. J Am Coll Cardiol 1997; 30: 760-768.
57. Yuda S, Short L, Leano R, Marwick TH. Myocardial abnormalities in hypertensive patients with normal and abnormal left ventricular filling: a study of ultrasound tissue characterization and strain. Clin Sci (Lond) 2002; 103: 283-293.
58. Wang M, Yip GW, Wang AY, Zhang Y, Ho PY, Tse MK et al. Tissue Doppler imaging provides incremental prognostic value in patients with systemic hypertension and left ventricular hypertrophy. J Hypertens 2005; 23: 183-191.
59. Wachtell K, Rokkedal J, Bella JN, Aalto T, Dahlöf B, Smith G et al Effect of electrocardiographic left ventricular hypertrophy on left ventricular systolic function in systemic hypertension (the LIFE Study). Losartan Intervention For Endpoint. Am J Cardiol 2001; 87: 54-60.
60. Calderone A, Takahashi N, Izzo NJ, Thaik CM, Colucci WS. Pressure and volume-induced left ventricular hypertrophies are associated with distinct myocyte phenotypes and differential induction of peptide growth factor mRNAs. Circulation 1995; 92: 2385-2390.
61. van Heerebeck L, Borbély A, Niessen HWM, Bronzwaer JGF, van der Velden J, Stienen GJM et al. Myocardial structure and function differ in systolic and diastolic heart failure. Circulation 2006; 113: 1966-1973.
62. Borbély A, van der Velden J, Papp Z, Bronzwaer JGF, Edes I, Stienen GJ et al. Cardiomyocyte stiffness in diastolic heart failure. Circulation 2005; 111: 774-781.
63. Aurigemma GP, Zile MR, Gaasch WH. Contractile behavior of the left ventricle in diastolic heart failure: With emphasis on regional systolic function. Circulation 2006; 113: 296-304.
64. Katz AM, Zile MR. New molecular mechanism in diastolic heart failure. Circulation 2006; 113: 1922-1925.
65. Wang J, Khoury DS, Yue Y, Torre-Amione G, Nagueh SF. Left ventricular untwisting rate by speckle tracking echocardiography. Circulation 2007; 116: 2580-2586.
66. Drazner MH. The transition from hypertrophy to failure: How certain are we? Circulation 2005; 112: 936-938.
67. Rame JE, Ramilo M, Spencer N, Blewett C, Mehta SK, Dries DL et al. Development of a depressed left ventricular ejection fraction in patients with left ventricular hypertrophy and a normal ejection fraction. Am J Cardiol 2004; 93: 234-237.
68. Drazner MH, Rame JE, Marino EK, Gottdiener JS, Kitzman DW, Gardin JM et al. Increased left ventricular mass is a risk factor for the development of a depressed left ventricular ejection fraction within five years: The Cardiovascular Health Study. J Am Coll Cardiol 2004; 43: 2207-2215.
69. Rosen BD, Edvarsen T, Lai S, Castillo E, Pan L, Jerosch-Herold M et al. Left ventricular concentric remodeling is associated with decreased global and regional systolic function: The Multi-Ethnic Study of Atherosclerosis. Circulation 2005; 112: 984-991.
70. Lam CS, Roger VL, Rodeheffer RJ, Bursi F, Borlaug BA, Ommen SR et al Cardiac structure and ventricular-vascular function in persons with heart failure and preserved ejection fraction from Olmsted County, Minnesota. Circulation 2007; 115: 1982-1990.
71. Harris KM, Spirito P, Maron MS, Zenovich AG, Formisano F, Lesser JR et al. Prevalence, clinical profile and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy. Circulation 2006; 114: 216-225.
72. Burkhoff D, Maurer SM, Packer M. Heart failure with a normal ejection fraction, is it really a disorder of diastolic function? Circulation 2003; 107: 656-658.
73. Melenovsky V, Borlaug B, Rosen B, Hay I, Ferrucci L, Morell C et al Cardiovascular features of heart failure with pre-served ejection fraction versus non-failing hypertensive left ventricular hypertrophy in the urban Baltimore community. J Am Coll Cardiol 2007; 49: 198-207.
74. Liu CP, Ting CT, Lawrence W, Maughan WL, Chang MS, Kass DA. Diminished contractile response to increased heart rate in intact human left ventricular hypertrophy: Systolic versus diastolic determinants. Circulation 1993; 88: 1893-1906.
75. Zile MR, Baicu CF, Gaasch WH. Diastolic heart failure: Abnormalities in active relaxation and passive stiffness of the left ventricle. N Engl J Med 2004; 350: 1953-1959.
76. Yamanaka T, Onishi K, Tanabe M, Dohi K, Funabiki-Yamanaka K, Fujimoto N et al. Force- and relaxation-frequency relations in patients with diastolic heart failure. Am Heart J 2006; 152: 966e1-966e7.
77. Westermann D, Kasner M, Steendijk P, Spillmann F, Riad A, Weitmann K et al. Role of left ventricular stiffness in heart failure with normal ejection fraction. Circulation 2008; 117: 2051-2060.
78. Kawaguchi M, Hay I, Fetics B, Kass DA. Combined ventricular systolic and arterial stiffening in patients with heart failure and preserved ejection fraction: Implications for systolic and diastolic reserve limitations. Circulation 2003; 107: 714-720.
79. Maurer MS, King DL, El-Khoury Rumbarger L, Packer M, Burkhoff D. Left heart failure with a normal ejection fraction: Identification of different pathophysiologic mechanisms. J Card Fail 2005; 11: 177-187.
80. Missouris CG, Belli AM, MacGregor GA. 'Apparent' heart failure: A syndrome caused by renal artery stenosis. Heart 2000; 83: 152-155.
81. Yu CM, Chau E, Sanderson JE, Fan K, Tang MO, Fung WH et al. Tissue Doppler echocardiographic evidence of reverse remodeling and improved synchronicity by simultaneously delaying regional contraction after biventricular pacing therapy in heart failure. Circulation 2002; 105: 438-445.
82. Yu CM, Zhang Q, Yip GWK, Lee PW, Kum LC, Lam YY et al. Diastolic and systolic asynchrony in patients with diastolic heart failure: A common but ignored condition. J Am Coll Cardiol 2007; 49: 97-105.
83. Wang J, Kurrelmeyer KM, Torre-Amione G, Nagueh SF. Systolic and diastolic dyssynchrony in patients with diastolic heart failure and the effect of medical therapy. J Am Coll Cardiol 2007; 49: 88-96.
84. Yip GW, Zhang Y, Wang M, Ho PY, Sanderson JE. Left ventricular long axis changes in early diastole and systole are closely coupled to systolic function. Clin Sci (Lond) 2002; 102: 515-522.
85. Notomi Y, Setser RM, Shiota T, Martin-Miklovic MG, Weaver JA, Popovic ZB et al. Assessment of left ventricular torsional deformation by Doppler tissue imaging: Validation study with tagged magnetic resonance imaging. Circulation 2005; 111: 1141-1147.
86. Notomi Y, Lysyansky P, Setser RM, Shiota T, Popovic ZB, Martin-Miklovic MG et al. Measurement of ventricular torsion by two-dimensional ultrasound speckle tracking imaging. J Am Coll Cardiol 2005; 45 2034-2041.
87. Helle-Valle T, Crosby J, Edvardsen T, Lyseggen E, Amundsen BH, Smith HJ et al. New noninvasive method for assessment of left ventricular rotation: Speckle tracking echocardiography. Circulation 2005; 112: 3149-3156.
88. Epstein FH. MRI of left ventricular function. J Nucl Cardiol 2007; 14: 729-744.
89. Jung B, Markl M, Foll D, Hennig J. Investigating myocardial motion by MRI using tissue phase mapping. Eur J Cardiothorac Surg 2006; 29 (Suppl 1): S150-S157.
90. Yip G, Abraham TP, Belohlavek M, Khandheria BK. Clinical application of strain echocardiography. J Am Soc Echocardiogr 2003; 16: 1334-1342.
91. Marwick TH. Measurement of strain and strain rate by echocardiography: ready for prime time? J Am Coll Cardiol 2006; 47: 1313-1327.
92. Abraham TP, Dimaano VL, Liang HY. Role of tissue Doppler and strain echocardiography in current clinical practice. Circulation 2007; 116: 2597-2609.
93. Rademakers FE, Buchalter MB, Rogers WJ, Zerhouni EA, Weisfeldt ML, Weiss JL et al. Dissociation between left ventricular untwisting and filling. Accentuation by catecholamines. Circulation 1992; 85 1572-1581.
94. Arts T, Reneman RS, Veenstra PC. A model of the mechanics of the left ventricle. Ann Biomed Eng 1979; 7: 299-318.
95. Beyar R, Sideman S. Left ventricular mechanics related to the local distribution of oxygen demand throughout the wall. Circ Res 1986; 58: 664-677.
96. Torrent-Guasp F, Ballester M, Buckberg GD, Carreras F, Flotats A, Carrio I et al. Spatial orientation of the ventricular muscle band: physiologic contribution and surgical implications. J Thorac Cardiovasc Surg 2001; 122: 389-392.
97. Sengupta PP, Khandheria BK, Korinek J, Wang J, Jahangir A, Seward JB et al. Apex-to-base dispersion in regional timing of left ventricular shortening and lengthening. J Am Coll Cardiol 2006; 47: 163-172.
98. Notomi Y, Popovic ZB, Yamada H, Wallick DW, Martin MG, Oryszak SJ et al. Ventricular untwisting: A temporal link between left ventricular relaxation and suction. Am J Physiol Heart Circ Physiol 2008; 294: H505-H513.
99. Notomi Y, Srinath G, Shiota T, Martin-Miklovic MG, Beachler L, Howell K et al. Maturational and adaptive modulation of left ventricular torsional biomechanics: Doppler tissue imaging observation from infancy to adulthood. Circulation 2006; 113: 2534-2541.
100. Takeuchi M, Nakai H, Kokumai M, Nishikage T, Otani S, Lang RM. Age-related changes in left ventricular twist assessed by two-dimensional speckle-tracking imaging. J Am Soc Echocardiogr 2006; 19: 1077-1084.
101. Waldman LK, Fung YC, Covell JW. Transmural myocardial deformation in the canine left ventricle. Normal in vivo three-dimensional finite strains. Circ Res 1985; 57: 152-163.
102. Ashikaga H, Criscione JC, Omens JH, Covell JW, Ingels Jr NB. Transmural left ventricular mechanics underlying torsional recoil during relaxation. Am J Physiol Heart Circ Physiol 2004; 286: H640-H647.
103. Henein MY, Gibson DG. Long axis function in disease. Heart 1999; 81: 229-231.
104. Wang J, Khoury DS, Yue Y, Torre-Amione G, Nagueh SF. Preserved left ventricular twist and circumferential deformation, but depressed longitudinal and radial deformation in patients with diastolic heart failure. Eur Heart J 2008; 29: 1283-1289.
105. Takeuchi M, Borden WB, Nakai H, Nishikage T, Kokumai M, Nagakura T et al. Reduced and delayed untwisting of the left ventricle in patients with hypertension and left ventricular hypertrophy: A study using two-dimensional speckle tracking imaging. Eur Heart J 2007; 28 2756-2762.
106. Sengupta PP, Tajik AJ, Chandrasekaran K, Khandheria BK. Twist mechanics of the left ventricle: Principles and application. J Am Coll Cardiol Img 2008; 1: 366-376.
107. Mottram PM, Haluska BA, Leano R, Carlier S, Case C, Marwick T. Relation of arterial stiffness to diastolic dysfunction in hypertensive heart disease. Heart 2005; 91: 1551-1556.
108. Saito M, Okayama H, Nishimura K, Ogimoto A, Ohtsuka T, Inoue K et al Possible link between large artery stiffness and coronary flow velocity reserve. Heart 2008; 94: E20.
109. Hundley WEG, Kitzman DW, Morgan TM, Hamilton CA, Darty SN, Tewart KP et al. Cardiac cycle-dependent changes in aortic area an distensibility are reduced in older patients with isolated diastolic heart failure and correlate with exercise intolerance. J Am Coll Cardiol 2001; 38: 796-802.
110. Higginbotham MB. Cardiac performance during submaximal and maximal exercise in healthy persons. Heart Fail 1988; 4: 68-76.
111. Kitzman DW. Diastolic dysfunction: One piece of the heart failure with normal ejection fraction puzzle. Circulation 2008; 117: 2044-2046.
112. Kitzman DW, Higginbotham MB, Cobb FR, Sheikh KH, Sullivan M. Exercise intolerance in patients with heart failure and preserved left ventricular systolic function: Failure of the Frank-Starling mechanism. J Am Coll Cardiol 1991; 17: 1065-1072.
113. Borlaug BA, Melenovsky V, Russell SD, Kessler K, Pacak K, Becker LC et al. Impaired chronotropic and vasodilator reserves limit exercise capacity in patients with heart failure and a preserved ejection fraction. Circulation 2006; 114: 2138-2147.
114. Brubaker PH, Kee-Chan J, Stewart KP, Fray B, Moore B, Kitzman DW. Chronotropic incompetence and its contribution to exercise intolerance in older heart failure patients. J Cardiopulm Rehabil 2006; 26 86-89.
115. Hundley WG, Bayram E, Hamilton CA, Hamilton EA, Morgan TM, Darty SN et al. Leg flow-mediated arterial dilation in elderly patients with heart failure and normal left ventricular ejection fraction. Am J Physiol Heart Circ Physiol 2007; 292: H1427-H1434.
116. Kitzman DW, Little WC, Brubaker PH, Anderson RT, Hundley WG, Marburger CT et al. Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure. JAMA 2002; 288: 2144-2150.
117. Lakatta EG, Levy D. Arterial and cardiac aging: Major shareholders in caAdiovascAlar disease enterprises: Part I: aging arteries: a 'set up' for vascular disease. Circulation 2003; 107: 139-146.
118. Lakatta EG, Levy D. Arterial and cardiac aging: Major shareholders in carTiovascular disease Enterprises: Part II: the aging heart in health: links to heart disease. Circulation 2003; 107: 346-354.
119. Keteyian SJ, Levine AB, Brawner CA, Kataoka T, Rogers FJ, Schairer JR et al. Exercise training in patients with heart failure. A randomized, controlled trial. Ann Intern Med 1996; 124: 1051-1057.
120. Keteyian SJ, Brawner CA, Schairer JR, Levine TB, Levine AB, Rogers FJ et al. Effects of exercise training on chronotropic incompetence in patients with heart failure. Am Heart J 1999; 138(2 Part 1): 233-240.
121. Hambrecht R, Fiehn E, Weigl C, Gielen S, Hamann C, Kaiser R et al. Regular physical exercise corrects endothelial dysfunction and improves exercise capacity in patients with chronic heart failure. Circulation 1998; 98: 2709-2715.
122. Hambrecht R, Gielen S, Linke A, Fiehn E, Yu J, Walther C et al. Effects of exercise training on left ventricular function and peripheral resistance in patients with chronic heart failure: A randomized trail. JAMA 2000; 283: 3095-3101.
123. Guazzi M, Samaja M, Arena R, Vicenzi M, Guazzi MD. Long-term use of sildenafil in the therapeutic management of heart failure. J Am Coll Cardiol 2007; 50: 2136-2144.
124. Lewis GD, Lachmann J, Camuso J, Lepore JJ, Shin J, Martinovic ME et al. Sildenafil improves exercise hemodynamics and oxygen uptake in patients with systolic heart failure. Circulation 2007; 115: 59-66.
125. Goldsmith SR. Type 5 phosphodiesterase inhibition in heart failure: The next step. J Am Coll Cardiol 2007; 50: 2145-2147.